The association between IMP2 and T2D was first identified through genome-wide association studies (GWAS) in 2007, with three independent research groups demonstrating a strong link between genetic variants in the IGF2BP2 gene and T2D risk [69,70,71]. The gene discussed is IGF2BP2; the disease is type 2 diabetes mellitus.